Clinical Trial Update: Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and pharmacodynamic effects of bosentan (Tracleer) in patients with pulmonary arterial hypertension caused by hypoxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hypoxia-Induced Pulmonary Artery Hypertension | Phase 1 | Status: COMPLETED